Insulet Corporation
PODD
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distribā¦ read more
Healthcare
Medical Devices
18 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$293.08
Price+0.07%
$0.19
1Y
Price
Market Cap
$20.617b
Large
Price/Earnings 3y Avg5y Avg
85.2x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+22.7%
EBITDA Margin+12.4%
Net Profit Margin+14.8%
Free Cash Flow Margin+22.7%
EBITDA Margin+12.4%
Net Profit Margin+14.8%
Free Cash Flow MarginRevenue
$2.522b
+21.7%
1y CAGR+24.6%
3y CAGR+23.2%
5y CAGREarnings
$246.200m
-41.1%
1y CAGR+1482.1%
3y CAGR+1093.5%
5y CAGREPS
$3.45
-40.3%
1y CAGR+1385.4%
3y CAGR+1021.1%
5y CAGRBook Value
$1.384b
$3.029b
Assets$1.645b
Liabilities$1.031b
DebtDebt to Assets
34.0%
2.3x
Debt to EBITDAFree Cash Flow
$421.200m
+37.9%
1y CAGR+218.9%
3y CAGR+184.1%
5y CAGRNo items found.
Press Releases
Statements and updates from the company